These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 4984340

  • 1. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A, Raafat H, Siddiqui GM.
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M, Tuchais E, Norval C, Carbonnelle B, Leroux MF, Corre C, Parvery F.
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract] [Full Text] [Related]

  • 4. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A, Ciobanu V, Cojocaru G, Borşaru I, Ciobanu D, Spirescu G, Roşianu D, Pescariu M.
    Ftiziologia; 1971 Jun; 20(6):623-8. PubMed ID: 5162289
    [No Abstract] [Full Text] [Related]

  • 5. [Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)].
    May P, König K.
    Z Urol Nephrol; 1969 Jun; 62(9):657-62. PubMed ID: 5408556
    [No Abstract] [Full Text] [Related]

  • 6. The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
    Tani P.
    Scand J Respir Dis Suppl; 1969 Jun; 69():15-6. PubMed ID: 4313500
    [No Abstract] [Full Text] [Related]

  • 7. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C, Kaufman S, Barcan F, Gheorghiu M, Cristea M, Ulpian C, Iancovici O.
    Ftiziologia; 1971 Jun; 20(4):373-9. PubMed ID: 5005706
    [No Abstract] [Full Text] [Related]

  • 8. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C, Flemming J.
    Acta Tuberc Pneumol Belg; 1969 Jun; 60(3):466-70. PubMed ID: 5371671
    [No Abstract] [Full Text] [Related]

  • 9. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G.
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [Abstract] [Full Text] [Related]

  • 10. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
    Radenbach KL.
    Scand J Respir Dis Suppl; 1969 May; 69():43-53. PubMed ID: 4906373
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M.
    Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
    [No Abstract] [Full Text] [Related]

  • 12. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C, Timoşca S, Petreanu V, Petreanu C, Georgescu M, Martinescu T.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982 Dec; 31(4):315-20. PubMed ID: 6304845
    [No Abstract] [Full Text] [Related]

  • 13. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
    Tsukamura M.
    Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C, Cornia G, Cirianni C, Garimoldi M, Ginesu F, Mandler F, Perna G, Pradella F.
    G Ital Chemioter; 1968 Oct; 15(4):92-4. PubMed ID: 5744843
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C, Andreis G.
    G Ital Chemioter; 1966 Oct; 13(1):109-27. PubMed ID: 4967318
    [No Abstract] [Full Text] [Related]

  • 16. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS.
    Probl Tuberk Bolezn Legk; 2008 Oct; (12):60-3. PubMed ID: 19227326
    [Abstract] [Full Text] [Related]

  • 17. Ethambutol in the re-treatment of multi-resistant advanced pulmonary tuberculosis (salvage cases).
    Roy DC, Sen PC, Bajpai BK.
    Indian J Chest Dis; 1974 Jul; 16(3):153-62. PubMed ID: 4422083
    [No Abstract] [Full Text] [Related]

  • 18. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B, Pretet S.
    Rev Tuberc Pneumol (Paris); 1970 Jul; 34(3):429-33. PubMed ID: 4994940
    [No Abstract] [Full Text] [Related]

  • 19. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance].
    Baba H, Takahashi R, Azuma Y.
    Kekkaku; 1971 Nov; 46(11):429-35. PubMed ID: 5004056
    [No Abstract] [Full Text] [Related]

  • 20. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK, Stead WW.
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.